Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform

被引：2

作者：

Hammerer-Lercher, Angelika ^{[1
]}

Griesmacher, Andrea ^{[1
]}

Poelzl, Gerhard ^{[2
]}

Brinskelle-Schmal, Natascha ^{[3
]}

Mair, Johannes ^{[2
]}

Frick, Matthias ^{[2
]}

Hawa, Gerhard ^{[3
]}

机构：

[1] Univ Innsbruck Hosp, Cent Inst Med & Chem Lab Diag, A-6020 Innsbruck, Austria

[2] Innsbruck Med Univ, Clin Internal Med 3, Innsbruck, Austria

[3] Biomed Med Prod GmbH & CoKG, Res & Dev, Vienna, Austria

来源：

CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2009年 / 47卷 / 10期

关键词：

assays; blood donors; heart failure; N-terminal pro B-type natriuretic peptide (NT-proBNP); BRAIN NATRIURETIC PEPTIDE; HEART-FAILURE; FORMS; PERFORMANCE; POPULATION; MARKERS; PLASMA;

D O I：

10.1515/CCLM.2009.279

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1305 / 1308

页数：4

共 13 条

[1] Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides [J].

Ala-Kopsala, M ;

Magga, J ;

Peuhkurinen, K ;

Leipälä, J ;

Ruskoaho, H ;

Leppäluoto, J ;

Vuolteenaho, A .

CLINICAL CHEMISTRY, 2004, 50 (09) :1576-1588

[2] N-Terminal pro-brain natriuretic peptide:: normal ranges in the pediatric population including method comparison and interlaboratory variability [J].

Albers, S ;

Mir, TS ;

Haddad, M ;

Läer, S .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (01) :80-85

[3] National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biomarkers of heart failure [J].

Apple, Fred S. ;

Wu, Alan H. B. ;

Jaffe, Allan S. ;

Panteghini, Mauro ;

Christenson, Robert H. ;

Apple, Fred S. ;

Cannon, Christopher P. ;

Francis, Gary ;

Jesse, Robert L. ;

Morrow, David A. ;

Newby, L. Kristen ;

Storrow, Alan B. ;

Tang, W. H. Wilson ;

Wu, Alan H. B. ;

Apple, Fred S. ;

Christenson, Robert H. ;

Jaffe, Allan S. ;

Pagani, Franca ;

Tate, Jillian ;

Ordonez-Llanos, Jordi ;

Mair, Johannes .

CIRCULATION, 2007, 116 (05) :E95-E98

[4]

Cauliez B, 2007, ANN BIOL CLIN-PARIS, V65, P93

[5] Analytical evaluation of the Dade Behring Dimension RxL automated N-terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010 [J].

Di Serio, F ;

Ruggieri, V ;

Varraso, L ;

De Sario, R ;

Mastrorilli, A ;

Pansini, N .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (11) :1263-1273

[6] Natriuretic peptides as markers of mild forms of left ventricular dysfunction:: Effects of assays on diagnostic performance of markers [J].

Hammerer-Lercher, A ;

Ludwig, W ;

Falkensammer, G ;

Müller, S ;

Neubauer, E ;

Puschendorf, B ;

Pachinger, O ;

Mair, J .

CLINICAL CHEMISTRY, 2004, 50 (07) :1174-1183

[7]

Karl J, 1999, SCAND J CLIN LAB INV, V59, P177

[8] Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population [J].

Lam, Carolyn S. P. ;

Burnett, John C., Jr. ;

Costello-Boerrigter, Lisa ;

Rodeheffer, Richard J. ;

Redfield, Margaret M. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (11) :1193-1202

[9] Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy [J].

Mikkelsen, KV ;

Bie, P ;

Moller, JE ;

Ryde, H ;

Videbæk, L ;

Haghfelt, T .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2005, 65 (08) :633-647

[10]

MISSBICHLER A, 1999, J LAB MED, V23, P241

← 1 2 →